Frey H - Search Results

1

Apolipoprotein E E4 allele and risk of dementia.

Pirttila T, Lehtimaki T, Nikkari T, Frey H, Mattila K. Pirttila T, et al. Among authors: frey h. JAMA. 1995 Feb 1;273(5):375; author reply 375-6. doi: 10.1001/jama.273.5.375. JAMA. 1995. PMID: 7880298 No abstract available.

2

Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease.

Lehtimäki T, Pirttilä T, Mehta PD, Wisniewski HM, Frey H, Nikkari T. Lehtimäki T, et al. Among authors: frey h. Hum Genet. 1995 Jan;95(1):39-42. doi: 10.1007/BF00225071. Hum Genet. 1995. PMID: 7814023

3

The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia.

Pirttilä T, Lehtimäki T, Rinne J, Mattila K, Frey H, Nikkari T. Pirttilä T, et al. Among authors: frey h. Acta Neurol Scand. 1996 May;93(5):352-4. doi: 10.1111/j.1600-0404.1996.tb00008.x. Acta Neurol Scand. 1996. PMID: 8800346

4

[Alzheimer's disease and the association of genetic polymorphism of apolipoprotein E and liquor beta protein in Finns].

Lehtimäki T, Pirttilä T, Frey H, Nikkari T. Lehtimäki T, et al. Among authors: frey h. Duodecim. 1995;111(5):401-7. Duodecim. 1995. PMID: 8674441 Finnish. No abstract available.

5

Dipeptidyl carboxypeptidase 1 (DCP1) and butyrylcholinesterase (BCHE) gene interactions with the apolipoprotein E epsilon4 allele as risk factors in Alzheimer's disease and in Parkinson's disease with coexisting Alzheimer pathology.

Mattila KM, Rinne JO, Röyttä M, Laippala P, Pietilä T, Kalimo H, Koivula T, Frey H, Lehtimäki T. Mattila KM, et al. Among authors: frey h. J Med Genet. 2000 Oct;37(10):766-70. doi: 10.1136/jmg.37.10.766. J Med Genet. 2000. PMID: 11015454 Free PMC article.

6

Altered blood-brain-barrier function in Alzheimer's disease?

Mattila KM, Pirttilä T, Blennow K, Wallin A, Viitanen M, Frey H. Mattila KM, et al. Among authors: frey h. Acta Neurol Scand. 1994 Mar;89(3):192-8. doi: 10.1111/j.1600-0404.1994.tb01660.x. Acta Neurol Scand. 1994. PMID: 8030400

7

Biomarkers in Alzheimer's disease?

Mattila KM, Frey H. Mattila KM, et al. Among authors: frey h. Pathol Biol (Paris). 1996 Oct;44(8):685-8. Pathol Biol (Paris). 1996. PMID: 8977925 Review. No abstract available.

8

The Glu318Gly mutation of the presenilin-1 gene does not necessarily cause Alzheimer's disease.

Mattila KM, Forsell C, Pirttilä T, Rinne JO, Lehtimäki T, Röyttä M, Lilius L, Eerola A, St George-Hyslop PH, Frey H, Lannfelt L. Mattila KM, et al. Among authors: frey h. Ann Neurol. 1998 Dec;44(6):965-7. doi: 10.1002/ana.410440617. Ann Neurol. 1998. PMID: 9851443

9

Problems associated with biological markers of Alzheimer's disease.

Frey HJ, Mattila KM, Korolainen MA, Pirttilä T. Frey HJ, et al. Neurochem Res. 2005 Dec;30(12):1501-10. doi: 10.1007/s11064-005-8827-7. Neurochem Res. 2005. PMID: 16362769

10

Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.

Pirttilä T, Kim KS, Mehta PD, Frey H, Wisniewski HM. Pirttilä T, et al. Among authors: frey h. J Neurol Sci. 1994 Dec 1;127(1):90-5. doi: 10.1016/0022-510x(94)90140-6. J Neurol Sci. 1994. PMID: 7699397

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,002 results

Search Page